SAR 216471 hydrochloride structure
|
Common Name | SAR 216471 hydrochloride | ||
|---|---|---|---|---|
| CAS Number | 1279829-64-9 | Molecular Weight | 599.511 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C28H31ClN8O3.HCl | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of SAR 216471 hydrochlorideSAR-216471 is a potent, highly selective, intravenous and oral, reversible P2Y12 receptor antagonist with binding IC50 of 17 nM; inhibits ADP-induced platelet aggregation in human platelet rich plasma with IC50 of 0.1 uM; exhibits an ED50 of 2.75mg/kg in ex vivo platelet aggregation model in rats. |
| Name | N-[6-(4-Butyryl-5-methyl-1H-pyrazol-1-yl)-3-pyridazinyl]-5-chloro-1-[2-(4-methyl-1-piperazinyl)-2-oxoethyl]-1H-indole-3-carboxamide hydrochloride (1:1) |
|---|---|
| Synonym | More Synonyms |
| Description | SAR-216471 is a potent, highly selective, intravenous and oral, reversible P2Y12 receptor antagonist with binding IC50 of 17 nM; inhibits ADP-induced platelet aggregation in human platelet rich plasma with IC50 of 0.1 uM; exhibits an ED50 of 2.75mg/kg in ex vivo platelet aggregation model in rats. |
|---|---|
| References | References 1. Boldron C, et al. J Med Chem. 2014 Sep 11;57(17):7293-316. 2. Delesque-Touchard N, et al. Thromb Res. 2014 Sep;134(3):693-703. View Related Products by Target P2Y Receptor |
| Molecular Formula | C28H31ClN8O3.HCl |
|---|---|
| Molecular Weight | 599.511 |
| Exact Mass | 598.197449 |
| InChIKey | UQLWHBMSQKUYAI-UHFFFAOYSA-N |
| SMILES | CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)nn2)c1C.Cl |
| 1H-Indole-3-carboxamide, 5-chloro-N-[6-[5-methyl-4-(1-oxobutyl)-1H-pyrazol-1-yl]-3-pyridazinyl]-1-[2-(4-methyl-1-piperazinyl)-2-oxoethyl]-, hydrochloride (1:1) |
| N-[6-(4-Butyryl-5-methyl-1H-pyrazol-1-yl)-3-pyridazinyl]-5-chloro-1-[2-(4-methyl-1-piperazinyl)-2-oxoethyl]-1H-indole-3-carboxamide hydrochloride (1:1) |